1Corewell Health East, Dearborn, USA
2Wayne State University, Detroit, USA.
American Journal of Medical Case Reports.
2023,
Vol. 11 No. 8, 150-151
DOI: 10.12691/ajmcr-11-8-5
Copyright © 2023 Science and Education PublishingCite this paper: Hussein Gaith, Jad Said, Antoine Egbe, Myles Hardeman, Priscella Holland. Hearing Loss and CLL: a Rare Complication of Leukostasis.
American Journal of Medical Case Reports. 2023; 11(8):150-151. doi: 10.12691/ajmcr-11-8-5.
Correspondence to: Hussein Gaith, Corewell Health East, Dearborn, USA. Email:
Hussein.Gaith@corewellhealth.orgAbstract
In chronic lymphocytic leukemia (CLL), hyperleukocytosis has a prevalence of 20-40%, but leukostasis is extremely rare. In this case, a 53-year-old male with no known medical history presented to the emergency department with acute bilateral hearing loss, shortness of breath, diffuse lymphadenopathy, weight loss, and an abdominal mass, and was found to have hyperleukocytosis (WBC: 1075.5 bil/L), anemia (Hb: 2.2 g/dL), and thrombocytopenia (Platelets: 33 bil/L). Flow cytometry and lymph node biopsy found chronic lymphocytic leukemia with a 13q14.3 deletion, and subsequently started on venetoclax resulting in resolution of the leukocytosis and thrombocytopenia. Persistent hearing loss led to attempting oral and intratympanic corticosteroids, which also failed to restore hearing. No lesions were found in the bilateral internal auditory canals on MRI. Unlike previous cases of hearing loss in CLL-related leukostasis, this patient's hearing loss did not resolve with CLL resolution, which suggests that increased viscosity versus other unidentified etiologies are the cause. Further studies need to be conducted in this subset of patients to better understand and combat the mechanisms behind CLL-related leukostasis hearing loss.
Keywords